Methylnaltrexone clinical trials
Also written Relistor, MOA-728 and MNTX.
How each study uses methylnaltrexone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the methylnaltrexone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 24 Apr 2008 · RELISTOR · NDA 021964 (FDA, Drugs@FDA)
- European Union
- 1 Jul 2008 · Relistor · EMEA/H/C/000870 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
59 studies that test it; most in 2007 (10)
| Year | Studies |
|---|---|
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 9 |
| 2007 | 10 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 6 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 40 · Other 19
Bausch Health Americas, Inc. (39) · University Medicine Greifswald (2) · Region Örebro County (2) · University of Missouri-Columbia (1) · Ohio State University (1) · Karolinska University Hospital (1) · University of Florida (1) · Universitaire Ziekenhuizen KU Leuven (1)
Often tested with
Tested in the same studies.
Naloxone (3) · Naloxegol (1) · Codeine (1) · Erythromycin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Opioid antagonists source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test methylnaltrexone.
- Dec 2026Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.Phase 4 · M.D. Anderson Cancer Center
- May 2027Chronic Widespread Pain in HIV: Novel Mechanisms and TherapeuticsNot applicable · Florida International University
Studies
Open first, then newest update. How each study uses methylnaltrexone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 59
- Chronic Widespread Pain in HIV: Novel Mechanisms and TherapeuticsRecruitingNot applicableFlorida International UniversityNCT04787848Written as Relistor Injectable ProductHow we know
- Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.RecruitingPhase 4M.D. Anderson Cancer CenterNCT06162377Written as MethylnaltrexoneHow we know
- Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced ConstipationCompletedPhase 4University of Missouri-ColumbiaNCT03523520Written as Methylnaltrexone Bromide 150 mg Oral TabletHow we know
- Naloxone and Intravenous Methylnaltrexone Effects on Bladder FunctionCompletedPhase 1Bausch Health Americas, Inc.NCT01367561Written as IV Methylnaltrexone (MNTX)How we know
- Subcutaneous Methylnaltrexone Versus Placebo for Postoperative Ileus PreventionCompletedPhase 2Ohio State UniversityNCT03852524Written as MethylnaltrexoneHow we know
- An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic CancerWithdrawnPhase 3Bausch Health Americas, Inc.NCT04151719Written as Methylnaltrexone bromide (MNTX)How we know
- A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic CancerWithdrawnPhase 2/3Bausch Health Americas, Inc.NCT04083651Written as Methylnaltrexone bromideHow we know
- Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant PainCompletedPhase 2Bausch Health Americas, Inc.NCT00605644Written as MOA-728How we know
- Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant PainCompletedPhase 2Bausch Health Americas, Inc.NCT00547586Written as N-methylnaltrexone bromide (MOA-728)How we know
- Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-ConstipationCompletedPhase 3Bausch Health Americas, Inc.NCT00936884Written as MethylnaltrexoneHow we know
- Evaluate the Pharmacokinetics (PK) of Methylnaltrexone (MNTX) in Healthy Adult SubjectsCompletedPhase 1Bausch Health Americas, Inc.NCT01366326Written as Methylnaltrexone bromideHow we know
- Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac RepolarizationCompletedPhase 1Bausch Health Americas, Inc.NCT01363323Written as Methylnaltrexone (MNTX)How we know
- Study Evaluating MOA-728 Administered in Healthy MenWithdrawnPhase 1Bausch Health Americas, Inc.NCT00427258Written as MOA-728How we know
- Study Evaluating Oral MOA-728 in Subjects on Methadone TherapyWithdrawnPhase 1Bausch Health Americas, Inc.NCT00505583Written as MOA-728How we know
- Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer SubjectsWithdrawnPhase 4Bausch Health Americas, Inc.NCT00858754Written as methylnaltrexoneHow we know
- Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative IleusCompletedPhase 2Bausch Health Americas, Inc.NCT01367548Written as IV Methylnaltrexone (MNTX)How we know
- Study of Pharmacokinetics, Safety and Tolerability of Intravenous Methylnaltrexone BromideCompletedPhase 1Bausch Health Americas, Inc.NCT01366365Written as methylnaltrexoneHow we know
- Tolerance and Pharmacokinetics Study of MNTX TabletsCompletedPhase 1Bausch Health Americas, Inc.NCT01366339Written as Oral methylnaltrexoneHow we know
- Effects of MNTX on CYP450 2D6 in Metabolizers of DextromethorphanCompletedPhase 1Bausch Health Americas, Inc.NCT01367535Written as IV Methylnaltrexone (MNTX)How we know
- Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous DoseCompletedPhase 1Bausch Health Americas, Inc.NCT01367496Written as IV Methylnaltrexone (MNTX)How we know
See all 59 studies that test methylnaltrexone →
Given beside what is tested · 1 — methylnaltrexone is usual care or a partner of the new treatment
Codes
What other systems call methylnaltrexone · ClinicalTrials.gg INT002974
- MeSH (NLM) C032257methylnaltrexoneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0RK7M7IABEMETHYLNALTREXONEConfirmed FDA, NLM
- RxNorm 29899One source FDA
- NCI Thesaurus C48403MethylnaltrexoneOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C032257 | methylnaltrexone | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0RK7M7IABE | METHYLNALTREXONE | Confirmed FDA, NLM |
| RxNorm | 29899 | — | One source FDA |
| NCI Thesaurus | C48403 | Methylnaltrexone | One source FDA |
Also registered as methylnaltrexone bromide (UNII RFO6IL3D3M · RxNorm 979111).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.